Paratek Pharmaceuticals, Inc.
PRTK · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $43 | $45 | $34 | $27 |
| Short-Term Investments | $0 | $0 | $0 | $30 |
| Receivables | $43 | $37 | $78 | $33 |
| Inventory | $11 | $14 | $17 | $21 |
| Other Curr. Assets | $9 | $15 | $8 | $11 |
| Total Curr. Assets | $105 | $111 | $137 | $121 |
| Property Plant & Equip (Net) | $2 | $2 | $2 | $2 |
| Goodwill | $1 | $1 | $1 | $1 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $38 | $37 | $32 | $33 |
| Total NC Assets | $41 | $40 | $36 | $36 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $146 | $151 | $173 | $157 |
| Liabilities | – | – | – | – |
| Payables | $3 | $5 | $5 | $8 |
| Short-Term Debt | $164 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $35 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $27 | $32 | $31 |
| Total Curr. Liab. | $203 | $33 | $37 | $39 |
| LT Debt | $96 | $259 | $258 | $259 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $49 | $48 | $48 | $25 |
| Total NC Liab. | $145 | $307 | $306 | $284 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $347 | $340 | $344 | $323 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$965 | -$951 | -$930 | -$923 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $764 | $761 | $759 | $757 |
| Total Equity | -$201 | -$189 | -$171 | -$166 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $146 | $151 | $173 | $157 |
| Net Debt | $217 | $214 | $224 | $232 |